Cargando…
CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with Chemotherapy
The prominent desmoplastic stroma of pancreatic ductal adenocarcinoma (PDAC) is a determinant factor in tumor progression and a major barrier to the access of chemotherapy. The PDAC microenvironment therefore appears to be a promising therapeutic target. CCN2/CTGF is a profibrotic matricellular prot...
Autores principales: | Resovi, Andrea, Borsotti, Patrizia, Ceruti, Tommaso, Passoni, Alice, Zucchetti, Massimo, Berndt, Alexander, Riser, Bruce L., Taraboletti, Giulia, Belotti, Dorina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226963/ https://www.ncbi.nlm.nih.gov/pubmed/32294968 http://dx.doi.org/10.3390/cells9040952 |
Ejemplares similares
-
Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth
por: Resovi, Andrea, et al.
Publicado: (2023) -
Alternative Vascularization Mechanisms in Tumor Resistance to Therapy
por: Belotti, Dorina, et al.
Publicado: (2021) -
Soluble stroma‐related biomarkers of pancreatic cancer
por: Resovi, Andrea, et al.
Publicado: (2018) -
CYR61/CCN1 expression in resected pancreatic ductal adenocarcinoma: A retrospective pilot study of the interaction between the tumors and their surrounding microenvironment
por: Abou-Kheir, Wassim, et al.
Publicado: (2020) -
Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment
por: Cruz-Monserrate, Zobeida, et al.
Publicado: (2014)